相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population
Kai Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Predictive Value of XRCC1 and XRCC3 Gene Polymorphisms for Risk of Ovarian Cancer Death After Chemotherapy
Chun-Xia Cheng et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors
Rebeka Sultana et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Base Excision Repair and Lesion-Dependent Subpathways for Repair of Oxidative DNA Damage
David Svilar et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
High XRCC1 Protein Expression Is Associated with Poorer Survival in Patients with Head and Neck Squamous Cell Carcinoma
Mei-Kim Ang et al.
CLINICAL CANCER RESEARCH (2011)
Variation in base excision repair capacity
David M. Wilson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
Current treatment and clinical trials in ovarian cancer
Liz Y. Han et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms
Rong Zhang et al.
TOXICOLOGY LETTERS (2010)
DNA Repair in Mammalian Cells
A. B. Robertson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
DNA Repair in Mammalian Cells
T. Nouspikel
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Gastric Cardia Carcinoma is Associated with the Promoter-77T>C Gene Polymorphism of X-Ray Cross-Complementing Group 1 (XRCC1)
Giovanni Corso et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
Xinchen Sun et al.
LUNG CANCER (2009)
Beyond chemotherapy: targeted therapies in ovarian cancer
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2009)
Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology
Sarah C. Shuck et al.
CELL RESEARCH (2008)
XRCC1 and DNA polymerase beta in cellular protection against cytotoxic DNA single-strand breaks
Julie K. Horton et al.
CELL RESEARCH (2008)
XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer
Kidong Kim et al.
GYNECOLOGIC ONCOLOGY (2008)
被撤回的出版物: Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase IIIα in a cell-cycle-specific manner (Retracted article. See vol. 81, pg. 5113, 2021)
Jill Moser et al.
MOLECULAR CELL (2007)
XRCC1 down-regulation in human cells leads to DNA-damaging agent hypersensitivity, elevated sister chromatid exchange, and reduced survival of BRCA2 mutant cells
Jinshui Fan et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Cancer pharmacogenomics - Role of DNA repair genetic Polymorphisms in individualizing cancer therapy
Lucy Gossage et al.
MOLECULAR DIAGNOSIS & THERAPY (2007)
Mouse models of XRCC1 DNA repair polymorphisms and cancer
WC Ladiges
ONCOGENE (2006)
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy
S Gurubhagavatula et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
分享论文
